Investor Contact

Media & Investor Relations:
Troy Wichterman 
Chief Financial Officer
(425) 402 - 1400

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc. 
P.O. Box 1342
Brentwood, New York 11717
(877) 830 - 4936

Investor Alerts

Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.

Press Releases

BioLife Solutions Announces CFO Retirement
Roderick de Greef Concludes 20 Year Association with BioLife

BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31, 2021 after a distinguished career with the Company. The Company has retained executive search firm Strawn Arnold to identify candidates to succeed Mr. de Greef.  Mr. de Greef will consult with the Company through March 31, 2022, to ensure an orderly transition of his duties.

Mike Rice, BioLife CEO, commented, "The entire team, our board and shareholders are extremely grateful to Rod for his 20+ years of contributing to the success of BioLife.  He was instrumental in securing funding in the early years and during his long tenure first as a board member and later as CFO, Rod has had an immeasurable positive impact as we scaled the business organically and though our acquisitions over the past two years. We will miss him but wish him the best in a well-deserved retirement."

De Greef added, "It has been a real honor to be a part of the team that has built BioLife to what it is today. The last five years as CFO have been particularly rewarding and a great capstone to a career spanning forty years. In the future, I look forward to watching the company continue to grow and thrive."

About BioLife Solutions

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic freezers, Stirling Ultracold ULT freezers, and SciSafe biologic materials storage. For more information, please visit,,, and follow BioLife on Twitter.


At the Company
Roderick de Greef
Chief Financial Officer
(425) 686-6002

LHA Investor Relations
Jody Cain
(310) 691-7100


SOURCE BioLife Solutions, Inc.